Singulex, Inc., a biotechnology company, develops and commercializes direct molecular detection technology solutions. Its solutions enable life science researchers and clinicians to understand and manage disease. The company develops biomarker diagnostic systems that can detect and quantify normal and abnormal protein biomarkers. It is conducting pilot studies to validate Erenna BioAssay System, a digital molecule detection platform, which detects and quantifies molecule biomarkers in clinical samples. The company also offers various custom assay services, such as pilot study services, assay prototyping, assay characterization, and assay validation. The company was formerly known as BioProfile Corporation and changed its name to Singulex, Inc in September 2003. Singulex is based in Hayward, California
Company growth
Type
Private
HQ
Alameda, US
Founded
2003
Size (employees)
200 (est)+3%
Singulex was founded in 2003 and is headquartered in Alameda, US

Key People at Singulex

Guido Baechler

Guido Baechler

President and Chief Executive Officer
Michael Bell

Michael Bell

Chief Financial Officer
Peter Heseltine

Peter Heseltine

CMO
William Hammack

William Hammack

Vice President Human Resources
Jeffrey Bishop

Jeffrey Bishop

VP, Research and Development
Karen Richards

Karen Richards

VP, Regulatory Affairs and Quality Assurance

Singulex Office Locations

Singulex has office in Alameda
Alameda, US

Singulex Metrics

Singulex Summary

Founding Date

2003

Total Funding

$137 M

Latest funding size

$50 M

Time since last funding

9 months

Investors

We estimate that Singulex's latest funding round in June 2016 was $50 M. In total, Singulex has raised $137 M

Singulex Online Presence

Singulex Company Life

You may also be interested in